Reovirus vaccines and methods of use therefor
AssigneeVanderbilt University
InventorsTerence S. Dermody, Karl W. Boehme, Mine Ikizler, Gregory J. Wilson, James D. Chappell
Life of this patent
Estimating the term…
Abstract
The present invention provides for modified reoviruses that carry α-helical epitopes from a variety of pathogens, as well as methods of using such modified reoviruses to generate immune responses against those epitopes in hosts.
Claims37
A modified reovirus σ1 protein comprising a first antigenic epitope from a non-reovirus antigen located in α-helical region of said protein.
(canceled)
(canceled)
9-40. (canceled)
A reovirus vector encoding a reovirus σ1 protein comprising a first antigenic epitope from a non-reovirus antigen located in α-helical region of said protein.
42-50. (canceled)
A reovirus particle comprising a vector encoding a reovirus σ1 protein comprising a first antigenic epitope from a non-reovirus antigen located in α-helical region of said protein.
The reovirus particle of claim 56, wherein said second copy is inserted into said α-helical region of said protein.
58-60. (canceled)
A method of inducing an immune response in a subject comprising providing to said subject a modified reovirus σ1 protein comprising a first antigenic epitope from a non-reovirus antigen located in α-helical region of said protein.
(canceled)
(canceled)
69-79. (canceled)
The method of claim 72, wherein said second epitope replaces one or more heptad repeats in said α-helical region of said protein.
(canceled)
(canceled)
86-100. (canceled)
A method of expressing an epitope in a subject comprising providing to said subject a modified reovirus σ1 protein comprising a first antigenic epitope from an antigen located in α-helical region of said protein.
102-108. (canceled)
Dependencies are inferred from the claim text.